Estradiol And Progesterone has 10 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Carbamazepine, Clarithromycin, Erythromycin. Patients taking Estradiol And Progesterone should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 10
- Moderate
- 10
Moderate (10)
- Estradiol And Progesterone + Carbamazepine— CYP3A4 inducer may reduce plasma concentrations of estrogens and progestins, possibly decreasing therapeutic effects and…
- Estradiol And Progesterone + Clarithromycin— CYP3A4 inhibitor may increase plasma concentrations of estrogen or progestin, resulting in adverse reactions.
- Estradiol And Progesterone + Erythromycin— CYP3A4 inhibitor may increase plasma concentrations of estrogen or progestin, resulting in adverse reactions.
- Estradiol And Progesterone + Grapefruit Juice— CYP3A4 inhibitor may increase plasma concentrations of estrogen or progestin, resulting in adverse reactions.
- Estradiol And Progesterone + Itraconazole— CYP3A4 inhibitor may increase plasma concentrations of estrogen or progestin, resulting in adverse reactions.
- Estradiol And Progesterone + Ketoconazole— CYP3A4 inhibitor may increase plasma concentrations of estrogen or progestin, resulting in adverse reactions.
- Estradiol And Progesterone + Phenobarbital— CYP3A4 inducer may reduce plasma concentrations of estrogens and progestins, possibly decreasing therapeutic effects and…
- Estradiol And Progesterone + Rifampin— CYP3A4 inducer may reduce plasma concentrations of estrogens and progestins, possibly decreasing therapeutic effects and…
- Estradiol And Progesterone + Ritonavir— CYP3A4 inhibitor may increase plasma concentrations of estrogen or progestin, resulting in adverse reactions.
- Estradiol And Progesterone + St. John'S Wort— CYP3A4 inducer may reduce plasma concentrations of estrogens and progestins, possibly decreasing therapeutic effects and…